The cost-effectiveness of oral HIV pre-exposure prophylaxis and early antiretroviral therapy in the presence of drug resistance among men who have sex with men in San Francisco-Reference-Cited by-同舟云学术

The cost-effectiveness of oral HIV pre-exposure prophylaxis and early antiretroviral therapy in the presence of drug resistance among men who have sex with men in San Francisco

Published:2018-04-24 Issue:1 Volume:16 Page:
ISSN:1741-7015
Container-title:BMC Medicine
language:en
Short-container-title:BMC Med

Author:

Shen Mingwang,Xiao Yanni,Rong Libin,Meyers Lauren Ancel,Bellan Steven E.

Funder

National Mega-project of Science Research

National Natural Science Foundation of China

National Science Foundation

US National Institute of General Medical Sciences Model of Infectious Disease Agent Study

National Institute of Allergy and Infectious Diseases K01 award

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12916-018-1047-1.pdf

Reference60 articles.

1. Holmes D. FDA paves the way for pre-exposure HIV prophylaxis. Lancet. 2012;380:325.

2. Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329:1168–74.

3. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363:2587–99.

4. Molina JM, Capitant C, Spire B, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015;373:2237–46.

5. Grant RM, Anderson PL, McMahan V, et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis. 2014;14:820–9.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A dynamic model and cost-effectiveness on screening coverage and treatment of syphilis included MSM population in the United States;Advances in Continuous and Discrete Models;2024-08-12

2. Role of ART and PrEP treatments in a stochastic HIV/AIDS epidemic model;Mathematics and Computers in Simulation;2024-07

3. Daily Oral Human Immunodeficiency Virus (HIV) Pre-exposure Prophylaxis Among Young Men Who Have Sex With Men in the United States: Cost-saving at Generic Drug Price;Clinical Infectious Diseases;2023-10-12

4. Preexposure Prophylaxis to Eliminate HIV in Taiwan by 2030: A Modeling Study;2023-10-06

5. Infectious Disease Modelling of HIV Prevention Interventions: A Systematic Review and Narrative Synthesis of Compartmental Models;PharmacoEconomics;2023-03-29